Enhanced PDE4B expression augments LPS-inducible TNF expression in ethanol-primed monocytes: Relevance to alcoholic liver disease

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 295, Issue 4, 2008, Pages

  Gobejishvili, Leila ^a   Barve, Shirish ^a,b   Joshi Barve, Swati ^a   McClain, Craig ^a,b,c  

^a UNIVERSITY OF LOUISVILLE HOSPITAL   (United States)

^b University of Louisville School of Medicine   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CYCLIC AMP; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; PHOSPHODIESTERASE 4B INHIBITOR; PHOSPHODIESTERASE INHIBITOR; ROLIPRAM; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALCOHOL LIVER DISEASE; ANIMAL CELL; ARTICLE; DOWN REGULATION; HUMAN; HUMAN CELL; KUPFFER CELL; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; CELLS, CULTURED; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 4; DOWN-REGULATION; ETHANOL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEPATITIS, ALCOHOLIC; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MONOCYTES; NF-KAPPA B; TUMOR NECROSIS FACTOR-ALPHA;

EID: 57349120536     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.90232.2008     Document Type: Article

References (39)

1. Barnes PJ, Karin M. Nuclear factor-kB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336: 1066-1071, 1997.
2. Bird GL, Sheron N, Goka AK, Alexander GJ, Williams RS. Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann Intern Med 112: 917-920, 1990.
3. Draheim R, Egerland U, Rundfeldt C. Anti-inflammatory potential of the selective phosphodiesterase 4 inhibitor N-(3,5-dichloro-pyrid-4-yl)-[1-(4- fluorobenzyl)-5-hydroxy-indole-3-yl]-glyoxylic acid amide (AWD 12-281), in human cell preparations. J Pharmacol Exp Ther 308: 555-563, 2004.
4. Essayan DM. Cyclic nucleotide phosphodiesterases. J Allergy Clin Immunol 108: 671-680, 2001.
5. Felver ME, Mezey E, McGuire M, Mitchell MC, Herlong HF, Veech GA, Veech RL. Plasma tumor necrosis factor alpha predicts decreased long-term survival in severe alcoholic hepatitis. Alcohol Clin Exp Res 14: 255-259, 1990.
6. Gobejishvili L, Barve S, Joshi-Barve S, Uriarte S, Song Z, McClain CJ. Chronic ethanol mediated decrease in cellular cAMP leads to enhanced LPS-inducible NFkB activity and TNF expression in macrophages: Relevance to alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol 291: G681-G688, 2006.
7. Haas JG, Baeuerle PA, Riethmuller G, Ziegler-Heitbrock HW. Molecular mechanisms in down-regulation of tumor necrosis factor expression. Proc Natl Acad Sci USA 87: 9563-9567, 1990.
8. Hill DB, Barve S, Joshi-Barve S, McClain C. Increased monocyte nuclear factor-kappaB activation and tumor necrosis factor production in alcoholic hepatitis. J Lab Clin Med 135: 387-395, 2000.
9. Hill DB, Shedlofsky SI, Schmidt J, Cohen D, McClain CJ. In vitro tumor necrosis factor cytotoxicity in HepG2 liver cells. Proceedings of the 1992 Conference on Alcohol, Drugs of Abuse, and Immunomodulators (AIDS). New York: Pergammon, 1993, p. 245-249.
10. Jin SL, Conti M. Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-alpha responses. Proc Natl Acad Sci USA 99: 7628-7633, 2002.
11. Jin SL, Lan L, Zoudilova M, Conti M. Specific role of phosphodiesterase 4B in lipopolysaccharide-induced signaling in mouse macrophages. J Immunol 175: 1523-1531, 2005.
12. Khoruts A, Stahnke L, McClain CJ, Logan G, Allen JI. Circulating tumor necrosis factor, interleukin-1 and interleukin- 6 concentrations in chronic alcoholic patients. Hepatology 13: 267-276, 1991.
13. Kim JS, Bailey MJ, Ho AK, Møller M, Gaildrat P, Klein DC. Daily rhythm in pineal phosphodiesterase (PDE) activity reflects adrenergic/3′,5′-cyclic adenosine 5′-monophosphate induction of the PDE4B2 variant. Endocrinology 148: 1475-1485, 2007.
14. Kishore R, McMullen MR, Nagy LE. Stabilization of tumor necrosis factor α mRNA by chronic ethanol: role of A + U-rich elements and p38 mitogen-activated protein kinase signaling pathway. J Biol Chem 276: 41930-41937, 2001.
15. Lee E, Marsano L, McClain CJ. #275 Veterans Cooperative Study. Liver cytokines in alcoholic hepatitis as assessed by immunohistochemistry (Abstract). Hepatology 14: A141, 1991.
16. Kwak HJ, Song JS, No ZS, Song JH, Yang SD, Cheon HG. The inhibitory effects of roflumilast on lipopolysaccharide-induced nitric oxide production in RAW 264.7 cells are mediated by heme oxygenase-1 and its product carbon monoxide. Inflamm Res 54: 508-513, 2005.
17. -ΔΔCt method. Methods 25: 402-408, 2001.
18. Lugnier C. Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents. Pharmacol Ther 109: 366-398, 2006.
19. McClain CJ, Barve S, Deaciuc I, Kugelmas M, Hill D. Cytokines in alcoholic liver disease. Semin Liver Dis 19: 205-219, 1999.
20. McClain CJ, Cohen DA. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology 9: 349-351, 1989.
21. McClain CJ, Hill DB, Marsano L, Cohen D, Shedlofsky S. A role for cytokines in alcoholic hepatitis. Proceedings of the 1992 Conference on Alcohol, Drugs of Abuse, and Immunomodulators (AIDS). New York: Pergammon, 1993, p. 133-141.
22. McClain CJ, Hill DB, Schmidt J, Diehl AM. Cytokines and alcoholic liver disease. Semin Liver Dis 13: 170-182, 1993.
23. Molnar-Kimber KL, Yonno Heaslip R, Weichman B. Modulation of TNF alpha and IL-1beta from endotoxin-stimulated monocytes by selective PDE enzyme inhibitors. Agents Actions 39: C77-C79, 1993.
24. Muller JM, Ziegler-Heitbrock HW, Baeuerle PA. Nuclear factor kappa B, a mediator of lipopolysaccharide effects. Immunobiology 187: 233-256, 1993.
25. Newman WH, Zhang LM, Lee DH, Dalton ML, Warejcka DJ, Castresana MR, Leeper-Woodford SK. Release of tumor necrosis factor-alpha from coronary smooth muscle: activation of NF-kappaB and inhibition by elevated cyclic AMP. J Surg Res 80: 129-135, 1998.
26. O'Donnell PM, Taffet SM. The proximal promoter region is essential for lipopolysaccharide induction and cyclic AMP inhibition of mouse tumor necrosis factor-alpha. J Interferon Cytokine Res 22: 539-548, 2002.
27. Ohlinger W, Dinges HP, Zatloukal K, Mair S, Gollowitsch F, Denk H. Immunohistochemical detection of tumor necrosis factor-alpha, other cytokines and adhesion molecules in human livers with alcoholic hepatitis. Virchows Arch A Pathol Anat Histopathol 423: 169-176, 1993.
28. Ollivier V, Parry GCN, Cobb RR, Prost DD, Mackman N. Elevated cyclic AMP inhibits NF-kB-mediated transcription in human monocytic cells and endothelial cells. J Biol Chem 271: 20828-20835, 1996.
29. Ouagued M, Martin-Chouly CA, Brinchault G, Leportier-Comoy C, Depincé A, Bertrand C, Lagente V, Belleguic C, Pruniaux MP. The novel phosphodiesterase 4 inhibitor, CI-1044, inhibits LPS-induced TNF-alpha production in whole blood from COPD patients. Pulm Pharmacol Ther 18: 49-54, 2005.
30. Seldon PM, Meja KK, Giembycz MA. Rolipram, salbutamol and prostaglandin E2 suppress TNFalpha release from human monocytes by activating Type II cAMP-dependent protein kinase. Pulm Pharmacol Ther 18: 277-284, 2005.
31. Semmler J, Wachtel H, Endres S. The specific type IV phosphodiesterase inhibitor rolipram suppress TNF alpha production by human mononuclear cells. Int J Immunopharmacol 15: 409-413, 1993.
32. Shames BD, McIntyre RC, Bensard DD, Pulido EJ, Selzman CH, Reznikov LL, Harken AH, Meng X. Suppression of Tumor Necrosis Factor a Production by cAMP in Human Monocytes: Dissociation with mRNA Level and Independent of Interleukin-10. J Surg Res 99: 187-193, 2001.
33. Torphy TJ. Phosphodiesterase isozymes: molecular targets for novel anti-asthma agents. Am J Respir Crit Care Med 157: 351-370, 1998.
34. Vincenti MP, Burrell TA, Taffet SM. Regulation of NF-kappa B activity in murine macrophages: effect of bacterial lipopolysaccharide and phorbol ester. J Cell Physiol 150: 204-213, 1992.
35. Verghese MW, McConnell RT, Strickland AB, Gooding RC, Stimpson SA, Yarnall DP, Taylor JD, Furdon PJ. Differential regulation of human monocytes derived TNF alpha and IL-1 beta by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors. J Pharmacol Exp Ther 272: 1313-1320, 1995.
36. Woo MS, Jang PG, Park JS, Kim WK, Joh TH, Kim HS. Selective modulation of lipopolysaccharide-stimulated cytokine expression and mitogen-activated protein kinase pathways by dibutyryl-cAMP in BV2 microglial cells. Brain Res Mol Brain Res 113: 86-96, 2003.
37. Zhang Z, Bagby GJ, Stoltz D, Oliver P, Schwarzenberger PO, Kolls JK. Prolonged ethanol treatment enhances lipopolysaccharide/phorbol myristate acetate-induced tumor necrosis factor-alpha production in human monocytic cells. Alcohol Clin Exp Res 25: 444-449, 2001.
38. Zhao XJ, Oliver P, Song K, Schurr J, Zhang Z, Kolls JK. Chronic ethanol enhances ectodomain shedding in T cells and monocytes. Alcohol Clin Exp Res 28: 1399-1407, 2004.
39. Zidek Z. Adenosine - cyclic AMP pathways and cytokine expression. Eur Cytokine Netw 10: 319-328, 1999.